Carasent - Profitable growth on the horizon
2023-02-16 16:45:00
Redeye updates its estimates following Carasent’s Q4 2022 report, which showed stronger growth than what we had anticipated. Moreover, the organic growth rate pace increased from the previous quarter. Investments still weighed down near-term margins, but management signaled that it seeks to slow down new hires and start scaling margins again, in a few quarters' time, to our understanding.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/